Latest filing published 17 Jul 2026 for Nuvation Bio Inc., €76k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Philippe Sauvage discloses dealings in Nuvation Bio Inc. to SEC (Form 4). Over a trading history stretching from 16 June 2025 to 15 July 2026, the count stands at 4 filings.
No open-market sale appears; the market trades are 2 purchases worth €11k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 option exercises.
The latest filing, published on 17 July 2026, reports an option exercise of €76k in Nuvation Bio Inc. The last insider purchase was made public on 18 June 2025, 492 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations